Back

Safety and efficacy of catheter ablation in patients with atrial arrhythmias and cardiac amyloidosis: a systematic review and meta-analysis

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Catheter ablation general aspects Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Patricia Ximenes

Albert Einstein Israelite Hospital, Sao Paulo (Brazil)

6 More presentations in this session

Presentation thumbnail
Differences in feasibility and outcomes of catheter ablation using robotic magnetic navigation in patients with congenital heart disease depending on the complexity of the defect
Mr J. Malinowski (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Pulsed-field vs thermal catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy
Doctor M. Laredo (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Are there anatomic and geometric features of the pulmonary veins associated with reconnection after pulsed-field ablation of atrial fibrillation? a cardiac computed tomography study
Doctor M. Laredo (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Risk factors for redo procedures following ablation of accessory pathways in children. Multivariable analysis in a nationwide cohort study.
Doctor M. Turcsan (Budapest, HU)
Abstract Slides Video
Presentation thumbnail
Acute and long-term results of atrial fibrillation cryoablation guided by pressure waveforms: a multicentre registry
Doctor A. Fontenla Cerezuela (Pozuelo de Alarcon, Madrid, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Catheter ablation general aspects

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Catheter ablation for atrial fibrillation in patients with cardiac amyloidosis - Clinical characteristics and outcomes
thumbnail
Congress Presentation
Ablation therapy for atrial fibrillation in patients with attr-amyloidosis or diastolic dysfunction: evaluation of 12-month success rates
thumbnail
Congress Presentation
Management of arrhythmias in cardiac amyloidosis

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources